您的位置: 首页 > 农业专利 > 详情页

relationship farmaceutycznie permissible salt or its nucleoside for treatment or prophylaxis of hepatitis c virus infection
专利权人:
IDENIX (CAYMAN) LIMITED;UNIVERSITA DEGLI STUDI DI CAGLIARI
发明人:
PAULO LA COLLA,JEAN PIERRE SOMMADOSSI
申请号:
PL389775
公开号:
PL227118B1
申请日:
2001.05.23
申请国别(地区):
PL
年份:
2017
代理人:
摘要:
The present invention provides pharmaceutical compositions for the treatment of a hepatitis C infection in a host, comprising an antivirally effective amount of a 2'-C-branched nucleoside or a 2'-C-branched ribofuranosyl nucleoside, or pharmaceutically acceptable salts or esters thereof, in combination with one or more other anti-HCV agent. The present invention further provides the use of a 2'-C-branched nucleoside or a 2'-C-branched ribofuranosyl nucleoside, or pharmaceutically acceptable salts or esters thereof, in the manufacture of a medicament for the treatment of a hepatitis C infection in a host.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充